BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Genetown

  BIORCHESTRA Participated in Formulation and Delivery

  BIORCHESTRA is a leading RNA therapeutics company that develops novel RNA-based therapeutics and drug delivery systems for neurodegenerative diseases.

  May 12, 2022

   · 

  1 min read
• Business

  Suvoda and N-SIDE Announce Agreement to Deliver Integrated Clinical Trial Optimization and IRT Solutions for Real-Time Demand Planning

  Suvoda LLC, today announced they have entered into an agreement to partner with N-SIDE — a deeptech company that empowers organizations in the clinical trials industry to make better decisions and optimize the use of critical resources. 

  May 12, 2022

   · 

  4 min read
• Business

  Integrated BioPharma Reports Results for its Quarter Ended March 31, 2022

  Integrated BioPharma, Inc. reports its financial results for the fiscal quarter ended March 31, 2022.

  May 12, 2022

   · 

  5 min read
• Genetown

  Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities [CORRECTED]

  Zealand Pharma A/S announces that it has received information on transactions in Zealand shares or related securities by persons discharging managerial responsibilities.

  May 12, 2022

   · 

  2 min read
• Business

  Erasca Reports First Quarter 2022 Financial Results and Business Updates

  Erasca, Inc. reported financial results for the fiscal quarter ended March 31, 2022, and provided business updates.

  May 12, 2022

   · 

  10 min read
• Business

  CymaBay Reports First Quarter 2022 Financial Results and Provides Corporate Update

  CymaBay Therapeutics, Inc. announced corporate updates and financial results for the first quarter ended March 31, 2022.

  May 12, 2022

   · 

  10 min read
• Business

  Chinook Therapeutics Provides Business Update and Reports First Quarter 2022 Financial Results

  Chinook Therapeutics, Inc. provided a business update and reported financial results for the first quarter ended March 31, 2022.

  May 12, 2022

   · 

  12 min read
• Business

  Rezolute Reports Third Quarter Fiscal 2022 Financial Results and Highlights Company Progress

  Rezolute, Inc. announced its financial results for the third quarter of fiscal 2022 ended March 31, 2022.

  May 12, 2022

   · 

  7 min read